Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

1 month ago 49

A Biogen facility in Cambridge, Massachusetts.

Brian Snyder | Reuters

  1. Homepage
  2. Finance
  3. Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

Related

Bob Iger reflects on 10 years of Shanghai Disneyland as it defies the Chinese pullback

Bob Iger reflects on 10 years of Shanghai Disneyland as it d...

13 minutes ago 3
NBA to name winning bids for Europe teams in the coming months, deputy commissioner says

NBA to name winning bids for Europe teams in the coming mont...

16 hours ago 6
California’s counting on an IPO tax windfall. Several factors are complicating the equation

California’s counting on an IPO tax windfall. Several factor...

22 hours ago 12
RIGHT SIDEBAR TOP AD

Trending

1. dallas weather
2. halle open
3. berlin open
4. alex de minaur
5. juneteenth celebrations near me
6. matt dunlap
7. maris nichols
8. zohran mamdani democratic party critique
9. norman reedus
10. darren raddysh

Popular

Prince Harry makes surprise solo appearance at Knicks vs. Spurs game after skipping Trooping the Colour

Prince Harry makes surprise solo appearance at Knicks vs. Sp...

5 days ago 46
Paramount-WBD merger wins approval from DOJ, source says

Paramount-WBD merger wins approval from DOJ, source says

6 days ago 42
Drugmakers race to find a place in the next wave of obesity drugs

Drugmakers race to find a place in the next wave of obesity ...

5 days ago 39
‘Lion of Mesopotamia’: How Aymen Hussein beat tragedy to reach World Cup

‘Lion of Mesopotamia’: How Aymen Hussein beat tragedy to rea...

5 days ago 35
Fox to buy streaming device maker Roku for $22 billion

Fox to buy streaming device maker Roku for $22 billion

3 days ago 33
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions · Privacy Policy · DMCA · Cookie Policy · Advertise With Us ·

© Primetweets 2026. All rights are reserved